Market Overview

UPDATE: Morgan Stanley Reiterates On McKesson Following Investor Day

Related MCK
Healthcare Spending to Trend Up in 2015: 3 Healthcare Fund Picks - Best of Funds
15 Companies That Are Killing It With Equal Rights

In a report published Thursday, Morgan Stanley analyst Ricky R. Goldwasser reiterated an Overweight rating on McKesson (NYSE: MCK), and raised the price target from $197.00 to $205.00.

In the report, Morgan Stanley noted, “Investor day showcased MCK's mkt leadership, favorable ind trends and mgmt breadth. Incr margin targets highlight expansion levers, complemented by cap deployment. W/ strong generic inflation, Celesio & PSS synergies, and generic scale oppty, we view MCK as best positioned in group. PT to $205.”

McKesson closed on Wednesday at $187.35.

Posted-In: Morgan Stanley Ricky R. GoldwasserAnalyst Color Price Target Analyst Ratings

 

Most Popular

Related Articles (MCK)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters

Benzinga Professional